Dr. John Crawford, Medical Director, Neurology, Co-Medical Director, CHOC Neuroscience Institute
Dr. John Crawford is board-certified by the American Board of Psychiatry and Neurology in neurology with special qualifications in child neurology and by the United Council for Neurology Subspecialties in neuro-oncology. He graduated from the University of Massachusetts at Amherst with a Bachelor of Science in biochemistry and a master’s degree in biochemistry and molecular biology. Dr. Crawford attended medical school at the University of Massachusetts at Worcester. Following medical school, he completed his pediatrics training at Los Angeles County/University of California and child neurology and neuro-oncology training at Children’s National Medical Center. Prior to his arrival at CHOC, Dr. Crawford was professor of clinical neurosciences and pediatrics at University of California San Diego and director of neuro-oncology at Rady Children’s Hospital. As prior director of the Child Neurology Fellowship Program and Neuro-Oncology Fellowship Program at UCSD, Dr. Crawford has mentored dozens of neurology and oncology trainees throughout his career.
Dr. Crawford’s research interests are in translational pediatric neuro-oncology including molecular-guided approaches to the diagnosis and treatment of pediatric central nervous system tumors.
Peer Reviewed Publications
Kung MS, Crawford JR. Subacute Sclerosing Panencephalitis after Measles Infection. N Engl J Med. 2026 Feb 21. doi: 10.1056/NEJMicm2504828. Epub ahead of print. PMID: 41728896.
Berry JV, Tran BM, Wu G, Tan Z, Mendoza E, Kim M, Arat Z, Lin PSH, Valenzuela L, Holmes TC, Virovka A, Thaxton M, Nguyen M, Stein S, Sigaroudi VR, De La Rosa A, Gawronski B, Silva J, Gonzalez L, Wright S, Wood K, Hui GK, Anousaya D, Gangeddula VR, Gama N, Gama J, Gross T, Bunney B, Stein R, Sequeira PA, Mamdani F, Cartagena P, Bunney WE, Lou J, Park HL, Wilson A, Mark Brooks H, Allhusen V, Crawford J, Knight JM, Ren B, Ecker J, Margarita Behrens M, Dirk Keene C, Stark C, Head E, Yong W, Monuki E, Xu X. UC Irvine’s Brain Initiative Cell Atlas Network (BICAN) Brain Procurement Program for the Center for Multiomic Human Brain Cell Atlas Project. bioRxiv [Preprint]. 2025 Dec 26:2025.12.23.696304. doi: 10.64898/2025.12.23.696304. PMID: 41509448; PMCID: PMC12776169.
Gora A, Crawford JR. Neuroimaging features of 12q24.31-q24.33 duplication and Cri–du–Chat syndrome in an infant. BMJ Case Rep. 2026 Feb 19;19(2):e270458. doi: 10.1136/bcr-2025-270458. PMID: 41713888.
Levy DM, Owen MJ, Patel VA, Brandel MG, Nation J, Plonsker J, Crawford JR*, Levy ML*. Clinical outcomes and delayed proton therapy following endoscopic endonasal resection of large and giant pediatric craniopharyngiomas. Neurosurg Focus. 2026 Jun 1;60(6):E4. doi: 10.3171/2026.2.FOCUS251137. PMID: 42224719.* co-senior authors
Calvo Fernández E, Tomassoni L, Zhang X, Wang J, Obradovic A, Laise P, Griffin AT, Vlahos L, Minns HE, Morales DV, Simmons C, Gallitto M, Wei HJ, Martins TJ, Becker PS, Crawford JR, Tzaridis T, Wechsler-Reya RJ, Garvin J, Gartrell RD, Szalontay L, Zacharoulis S, Wu CC, Zhang Z, Califano A, Pavisic J. Systematic design of combination therapy by targeting master regulators of coexisting diffuse midline glioma cell states. Nat Genet. 2026 Apr 22. doi: 10.1038/s41588-026-02550-w. Epub ahead of print. PMID: 42020604.
Hsia B, Dongre R, Erquizi A, Guerra-Navarro PV, Bitar G, Alshaka SA, Kim JD, Valencia-Sanchez BA, Brandel MG, Sato M, Crawford JR, Levy ML, Patel VA, Polster SP. Molecular Profiling of Olfactory Neuroblastoma Using the AACR Project GENIE Database. J Neurol Surg B Skull Base. 2025 Jun 27;87(3):330-336. doi: 10.1055/a-2639-5690. PMID: 42095028; PMCID: PMC13143387.
Kieu Q, Chavan R, Le C, Crawford J Acute encephalopathy from Central Nervous System Hemophagocytic Lymphohistiocytosis (CNS HLH) in X‑linked lymphoproliferative disease type 1 (XLP-1). J Child Neurol 2026 (accepted)
N. D. Shah, A. Z. Kalawi, R. Pearson, A. Nael, and J. R. Crawford, “Mesenchymal Chondrosarcoma Presenting as Atypical Brown–Sequard Syndrome,” Annals of the Child Neurology Society (2026): 1-3, https://doi.org/10.1002/cns3.70079.
Owen MJ, Yang JH, Montenegro MA, Harvey H, Coufal NG, Levy ML, Crawford JR Posterior Reversible Encephalopathy Syndrome in Pediatric Brain Tumor Patients – A Distinct Entity Neuro-Oncol Pediatr. 2026 (accepted minor revisions)
Valencia BA, Cheng MZ, Kim JD, Brandel MG, Crawford JR, Plonsker J, Patel VA, Levy ML Endoscopic Endonasal Management of Giant Pediatric Craniopharyngioma Neurosurg. Focus 2026 (accepted minor revisions)
- Muscular dystrophy and muscle diseases
- Neural tube defects (spina bifida, encephalocele, anencephaly)
- Neurofibromatosis
- Sleep disorders
- Spasticity
- Spina bifida
- Spinal dysraphism
- Stroke
- Tics and Tourette syndrome
- Traumatic brain injuries (TBI) and other head injuries
John Crawford, MD, MS in the News
Cancer / Oncology
National brain mapping study receives its first ‘magical’ gift from patient with cancer
Ethan Nguyen is the first pediatric patient to become part of an NIH-funded study that began in 2022 and is led by UC Irvine.
Cancer / Oncology
Patient’s journey illustrates strength of neuro-oncology programs at CHOC, Rady Children’s
Trent Cirigliano, 13, spent two years at CHOC and Rady Children’s for treatment of a brain tumor that included proton therapy and a clinical trial.
Healthcare
Department of Defense grant boosts CHOC’s research into novel hydrocephalus treatment
CHOC Neuroscience Institute to study a non-surgical way to treat the debilitating and complex disease.
Healthcare
CHOC Research Day 2024 highlights pediatric brain health
Collaborative efforts of diverse experts from CHOC and UCI in neonatal brain health research seek to optimize pediatric neurodevelopmental outcomes.
Cancer / Oncology
Attacking pediatric brain tumors from both sides: An oncologist’s perspective
CHOC’s multidisciplinary team provides integrative molecular diagnosis and customized treatment plans for children with brain and spine tumors.
Cancer / Oncology
Attacking pediatric brain tumors from both sides: A neurologist’s perspective
CHOC brings leading-edge initiatives to pediatric brain tumor treatment through a collaboration between neurology, neurosurgery and oncology.